Medical chemistry in Eastern England--14th symposium: 10 April 2003, Hatfield, UK.
Norman
Peter
P
Norman Consulting, Burnham, Buckinghamshire, UK. petrosn@bigfoot.com
D002626:Chemistry, Pharmaceutical; D015195:Drug Design; D004358:Drug Therapy; D058785:GABA-A Receptor Agonists; D039041:Integrin alpha4beta1 / Q000037:antagonists & inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D058915:Purinergic P1 Receptor Antagonists; D058919:Purinergic P2 Receptor Antagonists; D011985:Receptors, Serotonin / Q000378:metabolism
D058785:GABA-A Receptor Agonists; D039041:Integrin alpha4beta1; D061965:Matrix Metalloproteinase Inhibitors; D004364:Pharmaceutical Preparations; D058915:Purinergic P1 Receptor Antagonists; D058919:Purinergic P2 Receptor Antagonists; D011985:Receptors, Serotonin; D010741:Phospholipases A